Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 2596.00 | 3777.75 | 0.6872 | 0.3851 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 1615.00 | 3777.75 | 0.4275 | -0.1298 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3367.00 | 3777.75 | 0.8913 | 0.7868 | |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5836.00 | 5946.00 | 0.9815 | 0.9499 | |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5967.00 | 5946.00 | 1.0035 | 1.0096 | |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 6124.00 | 5946.00 | 1.0299 | 1.0818 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 5000.00 | 3570.27 | 6025.00 | 5946.00 | 1.0133 | 1.0362 |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 5000.00 | 3570.27 | 6349.00 | 5946.00 | 1.0678 | 1.1864 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 5145.00 | 5946.00 | 0.8653 | 0.6430 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 5000.00 | 3570.27 | 3033.00 | 5946.00 | 0.5101 | -0.1988 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 3729.00 | 5946.00 | 0.6271 | 0.0609 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 5000.00 | 3570.27 | 6221.00 | 5946.00 | 1.0462 | 1.1267 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 6373.00 | 5946.00 | 1.0718 | 1.1977 | |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 5000.00 | 3570.27 | 2953.00 | 5946.00 | 0.4966 | -0.2274 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 6402.00 | 5946.00 | 1.0767 | 1.2113 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 3194.00 | 5946.00 | 0.5372 | -0.1404 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 5984.00 | 5946.00 | 1.0064 | 1.0174 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5493.00 | 5946.00 | 0.9238 | 0.7958 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 6129.00 | 5946.00 | 1.0308 | 1.0841 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 6409.00 | 5946.00 | 1.0779 | 1.2145 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 5000.00 | 3570.27 | 6073.00 | 5946.00 | 1.0214 | 1.0583 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 5000.00 | 3570.27 | 6236.00 | 5946.00 | 1.0488 | 1.1337 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 2544.00 | 5946.00 | 0.4279 | -0.3691 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 2602.00 | 5946.00 | 0.4376 | -0.3494 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5918.00 | 5946.00 | 0.9953 | 0.9872 |